Michael Ostland is currently the Head of Development Europe at Denali Therapeutics. Previously, Michael held various roles at Roche, including Lifecycle Leader and Head of Biostatistics at F. Hoffmann–La Roche Ltd. Michael has also served as Therapeutic Area Head of Statistics at Roche and Genentech. Michael holds a Ph.D. in Statistics from the University of California, Berkeley, and a Bachelor of Arts in Mathematics from UC San Diego.
Sign up to view 0 direct reports
Get started